The U.S. Securities and Exchange Commission (SEC) has approved sweeping changes to the Nasdaq Capital Market listing ...

Erasca continues developing novel RAS-pathway cancer drugs, backed by funding through 2027 and promising early results. Find ...

Nasdaq Inc. reports strong Q1 growth with rising revenues and EPS. Read more on how NDX is diversifying its business towards ...

Robert Half International faces weakening demand and macroeconomic headwinds, with disappointing 1Q25 results. Read why RHI ...

Learn about revenue growth, new dividend policy, and domain base trends. Explore strategic initiatives amid economic uncertainties.

U.S. stocks were roaring back to life following a disappointing start to the week. Notably, the rally in the Nasdaq 100 on ...

In recent years, U.S. options have seen significant growth in volume and overall interest from institutional investors, as these derivative products allow for greater risk management and downside ...

Investor appetite for dividend-paying stocks and exchange traded funds has gained significant momentum following April 2, 2025.

Q1 2025 Earnings Conference Call April 24, 2025 8:00 AM ETCompany ParticipantsAto Garrett - SVP and IR OfficerAdena Friedman ...

U.S. durable goods orders surged in March, but broader sector stagnation signals weaker economic growth in Q2 2025. Read more ...

Nasdaq CEO and chair Adena Friedman joins 'Squawk Box' to discuss the company's quarterly earnings results, what to make of ...

Sequoia Fund generated a total return of 4.64% 1 net of fees, versus negative 4.27% for the Standard and Poor’s 500 Index.